Table 2 Main study endpoints in the two study treatment groups
Frovatriptan | Almotriptan | p | |
|---|---|---|---|
Pain-relief episodes at 2 h | 28 (36) | 32 (41) | NS |
Pain-free episodes at 2 h | 15 (19) | 23 (29) | NS |
Pain-relief episodes at 4 h | 41 (53) | 38 (50) | NS |
Pain-free episodes at 4 h | 36 (47) | 42 (54) | NS |
Pain-relief episodes at 24 h | 48 (62) | 53 (67) | NS |
Pain-free episodes at 24 h | 46 (60) | 52 (67) | NS |
Recurrent episodes at 24 h | 6 (8) | 16 (21) | <0.05 |
Recurrent episodes at 48 h | 7 (9) | 19 (24) | <0.05 |